| Classical and novel strategies to develop a Shigella glycoconjugate vaccine: from concept to efficacy in human LA Barel, LA Mulard Human vaccines & immunotherapeutics 15 (6), 1338-1356, 2019 | 62 | 2019 |
| Convergent Chemoenzymatic Strategy to Deliver a Diversity of Shigella flexneri Serotype-Specific O-Antigen Segments from a Unique Lightly Protected … Z Hu, M Benkoulouche, LA Barel, G Le Heiget, A Ben Imeddourene, ... The Journal of Organic Chemistry 86 (3), 2058-2075, 2020 | 16 | 2020 |
| Redirecting substrate regioselectivity using engineered ΔN123-GBD-CD2 branching sucrases for the production of pentasaccharide repeating units of S. flexneri 3a, 4a and 4b haptens M Benkoulouche, A Ben Imeddourene, LA Barel, G Le Heiget, S Pizzut, ... Scientific Reports 11 (1), 2474, 2021 | 8 | 2021 |
| Development of carbon monoxide-releasing molecules conjugated to polysaccharides (glyco-CORMs) for delivering CO during obesity S Mohan, LA Barel, DE Benrahla, B Do, Q Mao, H Kitagishi, M Rivard, ... Pharmacological Research 191, 106770, 2023 | 4 | 2023 |
| Computer-aided engineering of a branching sucrase for the glucodiversification of a tetrasaccharide precursor of S. flexneri antigenic oligosaccharides M Benkoulouche, A Ben Imeddourene, LA Barel, D Lefebvre, M Fanuel, ... Scientific Reports 11 (1), 20294, 2021 | 4 | 2021 |
| Identification of a mechanism promoting mitochondrial sterol accumulation during myocardial ischemia–reperfusion: role of TSPO and STAR J Bréhat, S Leick, J Musman, JB Su, N Eychenne, F Giton, M Rivard, ... Basic Research in Cardiology, 1-23, 2024 | | 2024 |
| Protected tetrasaccharides, their process of preparation and their use as transglucosylase acceptor substrates in the chemo-enzymatic synthesis of shigella flexneri specific … L Mulard, G Le Heiget, HU Zhaohu, L Barel, I Andre, C Moulis, ... US Patent App. 18/463,658, 2024 | | 2024 |
| Protected tetrasaccharides, their process of preparation and their use as transglucosylase acceptor substrates in the chemo-enzymatic synthesis of Shigella flexneri specific … L Mulard, G Le Heiget, HU Zhaohu, L Barel, I Andre, C Moulis, ... US Patent 11,834,468, 2023 | | 2023 |
| Approche chimique et chimio-enzymatique innovante appliquée à des oligosaccharides de synthèse à visée vaccinale contre la dysenterie bacillaire LA Barel Université Paris Cité, 2019 | | 2019 |
